Invention Grant
- Patent Title: Factor IXa inhibitors
-
Application No.: US14652174Application Date: 2013-12-16
-
Publication No.: US09914727B2Publication Date: 2018-03-13
- Inventor: Cameron James Smith , John Qiang Tan , Ting Zhang , James Balkovec , William John Greenlee , Liangqin Guo , Yi-Heng Chen , Yili Chen , Samuel Chackalamannil , Tomokazu Hirabayashi , Mika Sekioka
- Applicant: Merck Sharp & Dohme Corp. , Mochida Pharmaceutical Co., Ltd.
- Applicant Address: US NJ Rahway JP Tokyo
- Assignee: Merck Sharp & Dohme Corp.,Mochida Pharmaceutical Co., Ltd.
- Current Assignee: Merck Sharp & Dohme Corp.,Mochida Pharmaceutical Co., Ltd.
- Current Assignee Address: US NJ Rahway JP Tokyo
- Agent Nicole M. Beeler; John C. Todaro
- International Application: PCT/US2013/075232 WO 20131216
- International Announcement: WO2014/099695 WO 20140626
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D413/12 ; C07D513/04
Abstract:
The present invention provides compounds of Formula (I) and pharmaceutical compositions comprising compounds of Formula I, and methods for using compounds of Formula I for treating or preventing thromboses, embolisms, hypercoaguability or fibrotic changes.
Public/Granted literature
- US20150329562A1 Factor IXa Inhibitors Public/Granted day:2015-11-19
Information query
